Last reviewed · How we verify
Standard Medical Care
Standard Medical Care is a Small molecule drug developed by Second Affiliated Hospital, School of Medicine, Zhejiang University. It is currently FDA-approved.
At a glance
| Generic name | Standard Medical Care |
|---|---|
| Sponsor | Second Affiliated Hospital, School of Medicine, Zhejiang University |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- A Study of Weight Loss Intervention With Tirzepatide and Progestin Intrauterine Device to Treat Endometrial Hyperplasia and Grade 1 Endometrial Cancer (PHASE2)
- Bedside Bike Early Mobilization Program for Inpatients (NA)
- Testing Whether Cemiplimab (REGN2810) Plus CDX-1140 Given Prior to Surgery Are Better Than Cemiplimab (REGN2810) Alone in Patients With Stage III-IV Head and Neck Cancer (PHASE2)
- Ablation Versus Medical Management of Atrial Fibrillation in HFpEF (NA)
- Perioperative Telemonitoring to Optimize Cancer Care and Outcomes (NA)
- Exercise for the Treatment of Cancer-Related Sarcopenia (NA)
- Structured Breastfeeding Education In Infants With Breast Refusal (NA)
- Evaluating the Addition of the Immunotherapy Drug Atezolizumab to Standard Chemotherapy Treatment for Advanced or Metastatic Neuroendocrine Carcinomas That Originate Outside the Lung (PHASE2, PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Standard Medical Care CI brief — competitive landscape report
- Standard Medical Care updates RSS · CI watch RSS
- Second Affiliated Hospital, School of Medicine, Zhejiang University portfolio CI
Frequently asked questions about Standard Medical Care
What is Standard Medical Care?
Standard Medical Care is a Small molecule drug developed by Second Affiliated Hospital, School of Medicine, Zhejiang University.
Who makes Standard Medical Care?
Standard Medical Care is developed and marketed by Second Affiliated Hospital, School of Medicine, Zhejiang University (see full Second Affiliated Hospital, School of Medicine, Zhejiang University pipeline at /company/second-affiliated-hospital-school-of-medicine-zhejiang-university).
What development phase is Standard Medical Care in?
Standard Medical Care is FDA-approved (marketed).